ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

Burton’s Clinic Reported Operating In Spite of Closure

December 13, 1985

ASCO Awards Contract For D.C. Office

January 5, 1990

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006

Funding Opportunities (8-page issue).

April 25, 2003

Moloney Out As Viral Oncology Chief, Names “Acting Assistant Director” Of NCI By Upton

January 6, 1978

Surgery Without Radiation Found Inadequate for DCIS

December 26, 2003